Report Detail

Other Covid-19 Impact on Artificial Pancreas Device System Market, Global Research Reports 2020-2021

  • RnM3969176
  • |
  • 15 May, 2020
  • |
  • Global
  • |
  • 94 Pages
  • |
  • QYResearch
  • |
  • Other

This report covers market size and forecasts of Artificial Pancreas Device System, including the following market information:
Global Artificial Pancreas Device System Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Artificial Pancreas Device System Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Artificial Pancreas Device System Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Artificial Pancreas Device System Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

Key market players
Major competitors identified in this market include Medtronic, Johnson & Johnson, TypeZero Technologies, Tandem Diabetes, Pancreum, Insulet, Beta Bionics, Animas Corporation, LLC, Bigfoot Biomedical, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Control-to-Range (CTR) System
Threshold Suspended Device System
Control - to - Target (CTT) System

Based on the Application:
Hospital
Clinic
Others


  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Artificial Pancreas Device System Industry
  • 1.7 COVID-19 Impact: Artificial Pancreas Device System Market Trends
  • 2 Global Artificial Pancreas Device System Quarterly Market Size Analysis

    • 2.1 Artificial Pancreas Device System Business Impact Assessment - COVID-19
      • 2.1.1 Global Artificial Pancreas Device System Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Artificial Pancreas Device System Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Artificial Pancreas Device System Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Artificial Pancreas Device System Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Artificial Pancreas Device System Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Artificial Pancreas Device System Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Artificial Pancreas Device System Market
    • 3.5 Key Manufacturers Artificial Pancreas Device System Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Artificial Pancreas Device System Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Control-to-Range (CTR) System
      • 1.4.2 Threshold Suspended Device System
      • 1.4.3 Control - to - Target (CTT) System
    • 4.2 By Type, Global Artificial Pancreas Device System Market Size, 2019-2021
      • 4.2.1 By Type, Global Artificial Pancreas Device System Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Artificial Pancreas Device System Price, 2020-2021

    5 Impact of Covid-19 on Artificial Pancreas Device System Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hospital
      • 5.5.2 Clinic
      • 5.5.3 Others
    • 5.2 By Application, Global Artificial Pancreas Device System Market Size, 2019-2021
      • 5.2.1 By Application, Global Artificial Pancreas Device System Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Artificial Pancreas Device System Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Medtronic
      • 7.1.1 Medtronic Business Overview
      • 7.1.2 Medtronic Artificial Pancreas Device System Quarterly Production and Revenue, 2020
      • 7.1.3 Medtronic Artificial Pancreas Device System Product Introduction
      • 7.1.4 Medtronic Response to COVID-19 and Related Developments
    • 7.2 Johnson & Johnson
      • 7.2.1 Johnson & Johnson Business Overview
      • 7.2.2 Johnson & Johnson Artificial Pancreas Device System Quarterly Production and Revenue, 2020
      • 7.2.3 Johnson & Johnson Artificial Pancreas Device System Product Introduction
      • 7.2.4 Johnson & Johnson Response to COVID-19 and Related Developments
    • 7.3 TypeZero Technologies
      • 7.3.1 TypeZero Technologies Business Overview
      • 7.3.2 TypeZero Technologies Artificial Pancreas Device System Quarterly Production and Revenue, 2020
      • 7.3.3 TypeZero Technologies Artificial Pancreas Device System Product Introduction
      • 7.3.4 TypeZero Technologies Response to COVID-19 and Related Developments
    • 7.4 Tandem Diabetes
      • 7.4.1 Tandem Diabetes Business Overview
      • 7.4.2 Tandem Diabetes Artificial Pancreas Device System Quarterly Production and Revenue, 2020
      • 7.4.3 Tandem Diabetes Artificial Pancreas Device System Product Introduction
      • 7.4.4 Tandem Diabetes Response to COVID-19 and Related Developments
    • 7.5 Pancreum
      • 7.5.1 Pancreum Business Overview
      • 7.5.2 Pancreum Artificial Pancreas Device System Quarterly Production and Revenue, 2020
      • 7.5.3 Pancreum Artificial Pancreas Device System Product Introduction
      • 7.5.4 Pancreum Response to COVID-19 and Related Developments
    • 7.6 Insulet
      • 7.6.1 Insulet Business Overview
      • 7.6.2 Insulet Artificial Pancreas Device System Quarterly Production and Revenue, 2020
      • 7.6.3 Insulet Artificial Pancreas Device System Product Introduction
      • 7.6.4 Insulet Response to COVID-19 and Related Developments
    • 7.7 Beta Bionics
      • 7.7.1 Beta Bionics Business Overview
      • 7.7.2 Beta Bionics Artificial Pancreas Device System Quarterly Production and Revenue, 2020
      • 7.7.3 Beta Bionics Artificial Pancreas Device System Product Introduction
      • 7.7.4 Beta Bionics Response to COVID-19 and Related Developments
    • 7.8 Animas Corporation
      • 7.8.1 Animas Corporation Business Overview
      • 7.8.2 Animas Corporation Artificial Pancreas Device System Quarterly Production and Revenue, 2020
      • 7.8.3 Animas Corporation Artificial Pancreas Device System Product Introduction
      • 7.8.4 Animas Corporation Response to COVID-19 and Related Developments
    • 7.9 LLC
      • 7.9.1 LLC Business Overview
      • 7.9.2 LLC Artificial Pancreas Device System Quarterly Production and Revenue, 2020
      • 7.9.3 LLC Artificial Pancreas Device System Product Introduction
      • 7.9.4 LLC Response to COVID-19 and Related Developments
    • 7.10 Bigfoot Biomedical
      • 7.10.1 Bigfoot Biomedical Business Overview
      • 7.10.2 Bigfoot Biomedical Artificial Pancreas Device System Quarterly Production and Revenue, 2020
      • 7.10.3 Bigfoot Biomedical Artificial Pancreas Device System Product Introduction
      • 7.10.4 Bigfoot Biomedical Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Artificial Pancreas Device System Supply Chain Analysis
      • 8.1.1 Artificial Pancreas Device System Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Artificial Pancreas Device System Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Artificial Pancreas Device System Distribution Channels
      • 8.2.2 Covid-19 Impact on Artificial Pancreas Device System Distribution Channels
      • 8.2.3 Artificial Pancreas Device System Distributors
    • 8.3 Artificial Pancreas Device System Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      Summary:
      Get latest Market Research Reports on Covid-19 Impact on Artificial Pancreas Device System. Industry analysis & Market Report on Covid-19 Impact on Artificial Pancreas Device System is a syndicated market report, published as Covid-19 Impact on Artificial Pancreas Device System Market, Global Research Reports 2020-2021. It is complete Research Study and Industry Analysis of Covid-19 Impact on Artificial Pancreas Device System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,250.00
      $4,875.00
      $6,500.00
      2,596.75
      3,895.13
      5,193.50
      3,042.00
      4,563.00
      6,084.00
      511,485.00
      767,227.50
      1,022,970.00
      271,342.50
      407,013.75
      542,685.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report